Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 1, 2012, Pages 74-81

  Sharma, Ketan ^a   Somavarapu, Satyanarayana ^a   Colombani, Agnes ^b   Govind, Nayna ^b   Taylor, Kevin M G ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Chitosan; Inhalation; Nanocarrier; Nanoparticle; Polyethylene glycol; Pressurized metered dose inhaler

Indexed keywords

ALKANE; CATION; CHITOSAN; HYDROFUOROALKANE; MACROGOL; MACROGOL 1000; MACROGOL 5000; MACROGOL 600; NANOCARRIER; NANOPARTICLE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; CROSS LINKING; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; METERED DOSE INHALER; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; SEDIMENT; ZETA POTENTIAL;

AEROSOL PROPELLANTS; AEROSOLS; CHITOSAN; CROSS-LINKING REAGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HYDROCARBONS, FLUORINATED; HYDROGEN-ION CONCENTRATION; LUNG; METERED DOSE INHALERS; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 84861095814     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.12.014     Document Type: Article

References (44)

1. J. Birchall Pulmonary delivery of nucleic acids Expert Opin. Drug Deliv. 4 2007 575 578
2. L.A. Dellamary, T.E. Tarara, D.J. Smith, C.H. Woelk, A. Adractas, M.L. Costello, H. Gill, and J.G. Weers Hollow porous particles in metered dose inhalers Pharm. Res. 17 2000 168 174
3. M.M. Bailey, and C.J. Berkland Nanoparticle formulations in pulmonary drug delivery Med. Res. Rev. 29 2009 196 212
4. N. Tsapis, D. Bennett, B. Jackson, D.A. Weitz, and D.A. Edwards Trojan particles: large porous carriers of nanoparticles for drug delivery Proc. Natl. Acad. Sci. USA 99 2002 12001 12005
5. C. Vauthier, and D. Labarre Modular biomimetic drug delivery systems J. Drug Deliv. Sci. Technol. 18 2008 59 68
6. C. Mayer Nanocapsules as drug delivery systems Int. J. Artif. Organs 28 2005 1163 1171
7. P.A. Dickinson, S.W. Howells, and I.W. Kellaway Novel nanoparticles for pulmonary drug administration J. Drug Target. 9 2001 295 302
8. B.K. Nyambura, I.W. Kellaway, and K.M.G. Taylor The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants Int. J. Pharm. 372 2009 140 146
9. R.O. Williams, M.K. Barron, J.M. Alonso, and C. Remuñán- López Investigation of a pMDI system containing chitosan microspheres and P134a Int. J. Pharm. 174 1998 209 222
10. B.K. Nyambura, I.W. Kellaway, and K.M.G. Taylor Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers Int. J. Pharm. 375 2009 114 122
11. L. Illum Chitosan and its use as a pharmaceutical excipient Pharm. Res. 15 1998 1326 1331
12. O. Felt, P. Buri, and R. Gurny Chitosan: a unique polysaccharide for drug delivery Drug Dev. Ind. Pharm. 24 1998 979 993
13. H.L. Luessen, B.J. de Leeuw, M.W. Langemeyer, A.B. de Boer, J.C. Verhoef, and H.E. Junginger Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo Pharm. Res. 13 1996 1668 1672
14. R. Fernandez-Urrusuno, P. Calvo, C. Remunan-Lopez, J.L. Vila-Jato, and M.J. Alonso Enhancement of nasal absorption of insulin using chitosan nanoparticles Pharm. Res. 16 1999 1576 1581
15. S.Y. Chae, M.K. Jang, and J.W. Nah Influence of molecular weight on oral absorption of water soluble chitosans J. Contr. Rel. 102 2005 383 394
16. A. Grenha, C.I. Grainger, L.A. Dailey, B. Seijo, G.P. Martin, C. Remuñán-López, and B. Forbes Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro Eur. J. Pharm. Sci. 31 2007 73 84
17. D.O. Corrigan, A.M. Healy, and O.I. Corrigan Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates Eur. J. Pharm. Biopharm. 62 2006 295 305
18. R.J. Pugh, T. Matsunaga, and F.M. Fowkes The dispersibility and stability of carbon black in media of low dielectric constant. 1. Electrostatic and steric contributions to colloidal stability Colloids Surfaces 7 1983 183 207
19. D. Traini, P.M. Young, P. Rogueda, and R. Price Investigation into the influence of polymeric stabilizing excipients on inter-particulate forces in pressurised metered dose inhalers Int. J. Pharm. 320 2006 58 63
20. A. Paul, P.C. Griffiths, and P.G. Rogueda Towards an understanding of adsorption behaviour in non-aqueous systems: adsorption of poly(vinyl pyrrolidone) and poly(ethylene glycol) onto silica from 2H,3H-perfluoropentane J. Pharm. Pharmacol. 57 2005 1383 1387
21. C. Vervaet, and P.R. Byron Drug-surfactant-propellant interactions in HFA-formulations Int. J. Pharm. 186 1999 13 30
22. G. Pilcer, and K. Amighi Formulation strategy and use of excipients in pulmonary drug delivery Int. J. Pharm. 392 2010 1 19
23. L. Wu, M. Al-Haydari, and S.R.P. Da Rocha Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes Eur. J. Pharm. Sci. 33 2008 146 158
24. A. Trapani, J. Sitterberg, U. Bakowsky, and T. Kissel The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs Int. J. Pharm. 375 2009 97 106
25. C. Colonna, B. Conti, P. Perugini, F. Pavanetto, T. Modena, R. Dorati, P. Iadarola, and I. Genta Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy Eur. J. Pharm. Biopharm. 70 2008 58 65
26. M. Huang, Z. Ma, E. Khor, and L.-Y. Lim Uptake of FITC-chitosan nanoparticles by A549 cells Pharm. Res. 19 2002 1488 1494
27. P. Bru, L. Brunel, H. Buron, I. Cayré, X. Ducarre, A. Fraux, O. Mengual, G. Meunier, A. de Sainte Marie, P. Snabre, Particle sizing and characterisation, in: Particle Sizing and Characterisation, 2004. pp. 45-60.
28. European Pharmacopoeia, Preparations for Inhalation (2.9.18), in: European Pharmacopoeia 6.0. 2008, Directorate for the Quality of Medicines of the Council of Europe: Strasbourg, pp. 287-300.
29. T.C. Carvalho, J.I. Peters, and R.O. Williams Influence of particle size on regional lung deposition - what evidence is there? Int. J. Pharm. 406 2011 1 10
30. M. Bivas-Benita, S. Romeijn, H.E. Junginger, and G. Borchard PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium Eur. J. Pharm. Biopharm. 58 2004 1 6
31. S. Mao, W. Sun, and T. Kissel Chitosan-based formulations for delivery of DNA and siRNA Adv. Drug Deliv. Rev. 62 2010 12 27
32. T. Sato, T. Ishii, and Y. Okahata In vitro gene delivery mediated by chitosan, Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency Biomaterials 22 2001 2075 2080
33. K. Mohri, T. Okuda, A. Mori, K. Danjo, and H. Okamoto Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation J. Contr. Rel. 144 2010 221 226
34. T. Kiang, J. Wen, H.W. Lim, and K.W.K.W. Leong The effect of the degree of chitosan deacetylation on the efficiency of gene transfection Biomaterials 25 2004 5293 5301
35. W. Sun, S. Mao, D. Mei, and T. Kissel Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin Eur. J. Pharm. Biopharm. 69 2008 417 425
36. R.P. Peguin, and S.R. da Rocha Solvent-solute interactions in hydrofluoroalkane propellants J. Phys. Chem. B 112 2008 8084 8094
37. K.B. Ridder, C.J. Davies-Cutting, and I.W. Kellaway Surfactant solubility and aggregate orientation in hydrofluoroalkanes Int. J. Pharm. 295 2005 57 65
38. R. Ashayer, P.F. Luckham, S. Manimaaran, and P. Rogueda Investigation of the molecular interactions in a pMDI formulation by atomic force microscopy Eur. J. Pharm. Sci. 21 2004 533 543
39. C. Celia, E. Trapasso, D. Cosco, D. Paolino, and M. Fresta Turbiscan Lab® expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent Colloids Surf. B Biointerfaces 72 2009 155 160
40. K.M.G. Taylor, Pulmonary drug delivery, in: Aulton's Pharmaceutics: The Design and Manufacture of Medicines, Churchill Livingstone, Edinburgh, 2007, pp. 539-554.
41. W. Stahlhofen, J. Gebhart, and J. Heyder Experimental determination of the regional deposition of aerosol particles in the human respiratory tract Am. Ind. Hyg. Assoc. J. 41 1980 385 398
42. J.L. Rau The inhalation of drugs: advantages and problems Respir. Care 50 2005 367 382
43. P.H. Hirst, G.R. Pitcairn, J.G. Weers, T.E. Tarara, A.R. Clark, L.A. Dellamary, G. Hall, J. Shorr, and S.P. Newman In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler Pharm. Res. 19 2002 258 264
44. I.M. El-Sherbiny, and H.D.C. Smyth Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres Int. J. Pharm. 395 2010 132 141